MassMutual Private Wealth & Trust
RAPP icon

MassMutual Private Wealth & Trust’s Rapport Therapeutics RAPP Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.48K Hold
163
– – ﹤0.01% 1586
2026
Q2 		$6.79K Hold
163
– – ﹤0.01% 1568
2026
Q1 		$5.1K Buy
163
+2
+1% +$56 ﹤0.01% 1669
2025
Q4 		$4.88K Buy
+161
New +$4.46K ﹤0.01% 1681

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

MassMutual Private Wealth & Trust's RAPP Position: Q3 2026 in Review

MassMutual Private Wealth & Trust held its Rapport Therapeutics (RAPP) position steady in Q3 2026 at 163 shares worth $5.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1586.

MassMutual Private Wealth & Trust first reported a position in RAPP in Q4 2025 and has held it in 4 quarters since. The position peaked at $6.79K in Q2 2026. 67 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

  • MassMutual Private Wealth & Trust held 163 shares of Rapport Therapeutics worth $5.48K as of Q3 2026.
  • MassMutual Private Wealth & Trust left its Rapport Therapeutics share count unchanged in Q3 2026.
  • Rapport Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1586 holding.
  • MassMutual Private Wealth & Trust first reported a position in Rapport Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • MassMutual Private Wealth & Trust's Rapport Therapeutics position peaked at $6.79K in Q2 2026.
  • 67 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.